Workboat Indexes
Articles published by Immunome, Inc.
![](https://mms.businesswire.com/media/20240812692309/en/405005/5/Immunome_Logo.jpg)
![](https://mms.businesswire.com/media/20240725411821/en/405005/5/Immunome_Logo.jpg)
Immunome Provides Update on Recent Business Development Activity Expected to Expand ADC Capabilities
July 25, 2024
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://mms.businesswire.com/media/20240627833859/en/405005/5/Immunome_Logo.jpg)
Immunome Appoints Phil Tsai as Chief Technical Officer
June 27, 2024
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://mms.businesswire.com/media/20240520133699/en/405005/5/Immunome_Logo.jpg)
![](https://mms.businesswire.com/media/20240517911577/en/405005/5/Immunome_Logo.jpg)
![](https://mms.businesswire.com/media/20240514845046/en/405005/5/Immunome_Logo.jpg)
![](https://mms.businesswire.com/media/20240508531812/en/405005/5/Immunome_Logo.jpg)
![](https://mms.businesswire.com/media/20240502691216/en/405005/5/Immunome_Logo.jpg)
![](https://mms.businesswire.com/media/20240405536897/en/405005/5/Immunome_Logo.jpg)
![](https://mms.businesswire.com/media/20240328336295/en/405005/5/Immunome_Logo.jpg)
Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets
March 28, 2024
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://mms.businesswire.com/media/20240326907197/en/405005/5/Immunome_Logo.jpg)
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
March 26, 2024
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 16, 2024
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Announces Pricing of Public Offering of Common Stock
February 13, 2024
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Announces Proposed Public Offering of Common Stock
February 13, 2024
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 05, 2024
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Appoints Phil Roberts as Chief Technical Officer
January 04, 2024
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Appoints Carol A. Schafer to Board of Directors
January 02, 2024
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome to Acquire Antibody-Related Assets and Materials from Atreca
December 26, 2023
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome to Present at the Stifel 2023 Healthcare Conference
November 10, 2023
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Reports Third Quarter 2023 Financial Results
November 09, 2023
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Appoints Jean-Jacques Bienaimé to Board of Directors
November 08, 2023
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Appoints Bob Lechleider, M.D., as Chief Medical Officer
October 19, 2023
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Immunome Reports Second Quarter 2023 Financial Results
August 09, 2023
From Immunome, Inc.
Via Business Wire
Tickers
IMNM
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.